Skip to main content

Applied Therapeutics, Inc.

APLTDelisted Feb 3, 2026
Industry
Pharmaceutical Preparations
SEC CIK
0001697532

Applied Therapeutics, Inc. was delisted on Feb 3, 2026; its insiders filed their last Form 4 on Feb 4, 2026; 52 institutions reported holding it in 13F filings for Q4 2025, worth $5.93M in total; no superinvestor held it.

13F holders, Q3 2024

Institutional positions in Applied Therapeutics, Inc. as of Sep 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
126
+33 vs. Q2 2024
Shares held
112.7M
+16.0M (+16.6%) vs. Q2 2024
Total value
$960.9M
+$509.9M (+113.0%) vs. Q2 2024
New holders
48
32 more added
Sold out
15
31 more reduced

1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q2 2024: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting APLT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ3 2024: 126 institutions
Q1 2021: 67 institutionsQ2 2021: 69 institutionsQ3 2021: 70 institutionsQ4 2021: 69 institutionsQ1 2022: 71 institutionsQ2 2022: 53 institutionsQ3 2022: 44 institutionsQ4 2022: 38 institutionsQ1 2023: 36 institutionsQ2 2023: 40 institutionsQ3 2023: 55 institutionsQ4 2023: 83 institutionsQ1 2024: 89 institutionsQ2 2024: 94 institutionsQ3 2024: 126 institutionsQ4 2024: 119 institutionsQ1 2025: 90 institutionsQ2 2025: 75 institutionsQ3 2025: 70 institutionsQ4 2025: 52 institutionsQ1 2026: 0 institutionsQ2 2026: 0 institutions
Value heldQ3 2024: $960.9M
Q1 2021: $278.6MQ2 2021: $319.3MQ3 2021: $250.9MQ4 2021: $133.6MQ1 2022: $26.0MQ2 2022: $25.3MQ3 2022: $21.1MQ4 2022: $15.1MQ1 2023: $15.6MQ2 2023: $40.3MQ3 2023: $107.0MQ4 2023: $205.8MQ1 2024: $638.6MQ2 2024: $481.8MQ3 2024: $960.9MQ4 2024: $98.5MQ1 2025: $51.8MQ2 2025: $27.4MQ3 2025: $57.2MQ4 2025: $5.93MQ1 2026: $0Q2 2026: $0
Institutions holding APLT and their total value by quarter
QuarterHoldersValue
Q2 20260$0
Q1 20260$0
Q4 202552$5.93M
Q3 202570$57.2M
Q2 202575$27.4M
Q1 202590$51.8M
Q4 2024119$98.5M
Q3 2024126$960.9M
Q2 202494$481.8M
Q1 202489$638.6M
Q4 202383$205.8M
Q3 202355$107.0M
Q2 202340$40.3M
Q1 202336$15.6M
Q4 202238$15.1M
Q3 202244$21.1M
Q2 202253$25.3M
Q1 202271$26.0M
Q4 202169$133.6M
Q3 202170$250.9M
Q2 202169$319.3M
Q1 202167$278.6M

Institutions, Q3 2024

Shares, value and share of portfolio for each institution holding Applied Therapeutics, Inc.; share changes are against Q2 2024.

Institutions holding APLT in Q3 2024
InstitutionSharesValue% of portfolioChange in sharesAction
Northern Trust Corp761,060$6.47M0.00%+527,276+225.5%Added
Integral Health Asset Management, LLC800,000$6.80M0.80%+800,000New
Goldman Sachs Group Inc817,766$6.95M0.00%+665,317+436.4%Added
Parkman Healthcare Partners LLC907,294$7.71M0.98%−241,013−21.0%Reduced
Alyeska Investment Group, L.P.981,673$8.34M0.04%−983,973−50.1%Reduced
Price T Rowe Associates Inc1,020,871$8.68M0.00%+990,196+3,228.0%Added
Vestal Point Capital, LP1,145,000$9.73M0.77%−4,285,000−78.9%Reduced
Opaleye Management Inc.1,320,000$11.2M1.87%−360,000−21.4%Reduced
StemPoint Capital LP1,554,586$13.2M3.96%−656,734−29.7%Reduced
Siren, L.L.C.1,633,768$13.9M0.70%+1,633,768New
Rock Springs Capital Management LP1,746,449$14.8M0.48%+191,445+12.3%Added
Geode Capital Management, LLC2,091,669$17.8M0.00%−7,146−0.3%Reduced
Tang Capital Management LLC2,730,000$23.2M1.66%+400,000+17.2%Added
Simplify Asset Management Inc.2,817,505$23.9M1.65%00.0%Unchanged
State Street Corp3,694,607$31.4M0.00%+2,038,724+123.1%Added
Adage Capital Partners GP, L.L.C.4,112,361$35.0M0.06%+1,337,577+48.2%Added
Deutsche Bank AG4,437,602$37.7M0.02%+2,094,119+89.4%Added
Vanguard Group Inc5,242,949$44.6M0.00%−79,511−1.5%Reduced
Knoll Capital Management, LLC5,574,687$47.4M22.89%00.0%Unchanged
Propel Bio Management, LLC6,567,858$55.8M32.38%00.0%Unchanged
BlackRock, Inc.6,942,699$59.0M0.00%+6,942,699New
Franklin Resources Inc6,800,910$60.5M0.02%−3,412,035−33.4%Reduced
Perceptive Advisors LLC8,005,000$68.0M1.46%00.0%Unchanged
VR Adviser, LLC9,825,000$83.5M4.37%+282,129+3.0%Added
Morgan Stanley9,904,530$84.2M0.01%+6,384,793+181.4%Added
Janus Henderson Group PLC10,541,528$89.7M0.05%+2,893,323+37.8%Added
Frazier Life Sciences Management, L.P.0$00.00%−2,286,135−100.0%Sold out
Artal Group S.A.0$00.00%−1,009,500−100.0%Sold out
Logos Global Management LP0$00.00%−600,000−100.0%Sold out
Checkpoint Capital L.P.0$00.00%−227,470−100.0%Sold out
Richmond Brothers, Inc.0$00.00%−61,827−100.0%Sold out
Jump Financial, LLC0$00.00%−53,235−100.0%Sold out
Two Sigma Investments, LP0$00.00%−43,338−100.0%Sold out
Commonwealth Equity Services, LLC0$00.00%−24,996−100.0%Sold out
Algert Global LLC0$00.00%−23,476−100.0%Sold out
Marathon Trading Investment Management LLC0$00.00%−15,907−100.0%Sold out
Bank of Montreal0$00.00%−12,200−100.0%Sold out
Principal Financial Group Inc0$00.00%−11,583−100.0%Sold out
Wolverine Trading, LLC0$00.00%−11,355−100.0%Sold out
Gsa Capital Partners LLP0$00.00%−10,917−100.0%Sold out
GWM Advisors LLC0$00.00%−199−100.0%Sold out
BlackRock Inc.––––Not filed